8-K
filed June 7, 2023, 7:59 PM ET
ticker BIAF
CIK 0001712762
other material
confidence high
sentiment neutral
materiality 0.60
bioAffinity Technologies stockholders approve increase in authorized shares to 25M and equity plan shares to 2M
bioAffinity Technologies, Inc.
- Authorized common shares increased from 14,285,715 to 25,000,000 via Certificate of Amendment filed June 6, effective June 7, 2023.
- Equity Incentive Plan share reserve increased from 1,142,857 to 2,000,000; plan became effective June 6, 2023.
- All seven director nominees elected; WithumSmith+Brown ratified as independent auditor for FY2023.
- Annual meeting quorum achieved with 6,433,619 votes representing 75.43% of voting power.
- Share increase and plan amendment both received affirmative votes from a majority of outstanding shares.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
bioAffinity Technologies, Inc.: Increased authorized shares of Common Stock from 14,285,715 to 25,000,000 (effective 2023-06-07).
- Change
- charter amendment
- Effective
- 2023-06-07
Exact text from the filing
to increase the number of shares of Common Stock authorized for issuance under the Certificate of Incorporation from 14,285,715 shares to 25,000,000 shares
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
bioAffinity Technologies, Inc. shareholders approved Amendment to Certificate of Incorporation to increase authorized shares from 14,285,715 to 25,000,000 at the 2023-06-06 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2023-06-06
Exact text from the filing
the Company’s stockholders voted at the Annual Meeting to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “ Certificate of Incorporation ”) to increase the number of shares of Common Stock authorized for issuance under the Certificate of Incorporation from 14,285,715 shares to 25,000,000 shares
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
bioAffinity Technologies, Inc. shareholders approved Amendment to the bioAffinity Technologies, Inc. 2014 Equity Incentive Plan to increase shares reserved from 1,142,857 to 2,000,000 at the 2023-06-06 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-06
Exact text from the filing
Proposal No. 2: Amendment to the bioAffinity Technologies, Inc. 2014 Equity Incentive Plan The stockholders approved the amendment to the Company’s Incentive Plan, resulting in the Amended and Restated Incentive Plan becoming effective on June 6, 2023, as discussed in
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
bioAffinity Technologies, Inc. shareholders approved Election of seven directors to serve on the Board until the next Annual Meeting at the 2023-06-06 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-06
Exact text from the filing
Proposal No. 1: Election of Directors . The stockholders elected each of the seven director nominees to serve on the Board until the 2024 Annual Meeting of Stockholders and until such director’s successor has been duly elected and qualified. The results of the vote taken were as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes Maria Zannes 4,812,018 16,564 81,181 1,523,856 Steven Girgenti 4,803,325 25,401 81,037 1,523,856 Robert Anderson 4,794,664 32,430 82,669 1,523,856 Stuart Diamond 4,803,266 25,260 81,237 1,523,856 Peter Knight 4,792,806 34,088 82,869 1,523,856 Mohsin Meghji 4,806,317 20,577 82,869 1,523,856 Gary Rubin 4,804,751 22,137 82,875 1,430,549
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.